comparemela.com

Latest Breaking News On - Immunotech - Page 1 : comparemela.com

AIM ImmunoTech : Quarterly Stockholder Conference Call - May 16, 2023

AIM ImmunoTech Quarterly Stockholder Conference Call AIM ImmunoTech management will host a conference call and webcastto discuss the Company s Q1 2023 operational. | May 11, 2023

Christopher mcaleerThomask equelsTech quarterly stockholder conference callChief executive officerTech conferenceAim immunotech inc stock exchangePress release023 aim us00901b1052

AIM ImmunoTech to Discuss First Quarter 2023 Financial Results on May 16, 2023 and Host Conference Call and Webcast

OCALA, Fla., May 09, 2023 AIM ImmunoTech Inc. , an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and. | May 9, 2023

United statesThomask equelsChristopher mcaleerJenene thomasImmunotech incChief executive officerTech conferenceAim immunotech inc stock exchangePress releaseMmune aim us00901b1052

AIM ImmunoTech Inc : AIM ImmunoTech Appoints Preeminent Biotechnology Pioneer, W Neal Burnette, Ph D , as Chairman of its Scientific Advisory Board (SAB)

Company's SAB is comprised of well-established leaders with expertise across biomedical research, academia, and pharmaceutical industry OCALA, Fla., April 12, 2023 (GLOBE NEWSWIRE) AIM ImmunoTech

United statesThomask equelsWilliam mitchellChristopher nicodemusRonald brusW neal burnetteUs army medical researchImmunotech incCollege of american pathologyAmerican society of investigative pathologyCollege of medicineDepartment of microbiology at howard universityTherapeutics incCompany on twitterAmerican association for the advancement of scienceYork academy of science

AIM ImmunoTech to Report Full Year 2022 Financial Results on March 31, 2023 and Host Inaugural Quarterly Conference Call and Webcast

OCALA, Fla., March 27, 2023 AIM ImmunoTech Inc. , an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and. | March 27, 2023

United statesChristopher mcaleerThomask equelsImmunotech incCompany on twitterChief executive officerTech conferenceAim immunotech inc stock exchangePress releaseMmune aim us00901b1052

AIM ImmunoTech Inc : AIM ImmunoTech Announces Late-Breaking Presentation at the International Conference on Antiviral Research Regarding Ampligen as a Potential Therapy Against Ebola Virus Disease

Growing body of data supports Ampligen's potential as both a prophylactic and an early-onset therapy against human Ebola virus disease outbreaksOCALA, Fla., March 16, 2023th International Conference on

United statesDennis riedlAngela coronaThomask equelsInternational society for antiviral researchEnvironmental sciencesInternational conference on antiviral researchImmunotech incEarly access programUniversity of cagliariDepartment of lifeEuropean medicines agencyInternational conference on antiviral researchdetailing ampligenNetherlands at erasmus medical centerAntiviral researchdetailing ampligenCentral africa

vimarsana © 2020. All Rights Reserved.